[AMRX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 64.70%
YoY- 92.30%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 599,046 559,355 535,075 464,662 404,642 413,787 259,871 14.92%
PBT 29,660 -232,731 34,824 -21,758 -56,227 -262,506 39,600 -4.70%
Tax -23 7,350 2,648 2,186 -5,701 -12,416 1,852 -
NP 11,917 -120,808 14,532 -11,996 -16,902 -219,445 37,446 -17.36%
Tax Rate 0.08% - -7.60% - - - -4.68% -
Total Cost 587,129 680,163 520,543 476,658 421,544 633,232 222,425 17.55%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 1.99 -21.60 2.72 -2.58 -4.18 -53.03 14.41 -28.09%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS 0.08 -0.80 0.10 -0.08 -0.13 -1.73 0.33 -21.02%
EPS Diluted 0.08 -0.80 0.10 -0.08 -0.13 -1.73 0.33 -21.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.